Showing results (21-30 of 319) with videos related to
Sort By:
Pageof 32
F1000Research|May 31, 2016
Current clinical immunotherapeutic approaches for head and neck cancerCarolina Soto Chervin, Bruce BrocksteinNature Clinical Practice. Oncology|January 30, 2007
The concurrent chemoradiation paradigm--general principlesTanguy Y Seiwert, Joseph K Salama, Everett E VokesLung Cancer (Amsterdam, Netherlands)|December 14, 2002
Adjuvant and neoadjuvant treatments for NSCLCEverett E Vokes, Hak Choy, David Gandara, et al.Seminars in Oncology|February 26, 2004
Cetuximab in cancers of the lung and head & neckEdward S Kim, Everett E Vokes, Merrill S KiesNature Clinical Practice. Oncology|March 1, 2007
The chemoradiation paradigm in head and neck cancerTanguy Y Seiwert, Joseph K Salama, Everett E VokesJournal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
The role of inhibitors of the epidermal growth factor in management of head and neck cancerBruce Brockstein, Mario Lacouture, Mark AgulnikJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2010
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304)Gregory A Otterson, Lydia Hodgson, Herbert Pang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
The expanding role of systemic therapy in head and neck cancerEzra E W Cohen, Mark W Lingen, Everett E VokesAmerican Journal of Clinical Oncology|December 9, 2008
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II ConsortiumHedy Lee Kindler, Mebea Aklilu, Sreenivasa Nattam, et al.Pageof 32